Metabolite 2-aminoadipic acid: implications for metabolic disorders and therapeutic opportunities
- PMID: 40432896
- PMCID: PMC12106402
- DOI: 10.3389/fphar.2025.1569020
Metabolite 2-aminoadipic acid: implications for metabolic disorders and therapeutic opportunities
Abstract
Previous evidence has indicated that the role of 2-aminoadipic acid (2-AAA), a derivative of lysine catabolism, in mediating specific detrimental effects on glial cells, notably inhibiting astrocyte activation. In addition, intrathecal administration of 2-AAA has demonstrated significant efficacy in relieving mechanical hyperalgesia. With the growing application of metabolomics in biomedical research, substantial evidence now underscores 2-AAA's pivotal role in regulating glucose and lipid metabolism. As a novel biomarker, 2-AAA is linked to increased susceptibility to diabetes and has emerged as a critical regulator of glucose homeostasis. This review explores recent advancements in understanding 2-AAA's potential therapeutic applications, particularly in the context of metabolic diseases such as diabetes, obesity, and atherosclerosis. It also addresses existing research gaps and outlines future directions for developing 2-AAA-based therapies.
Keywords: 2-aminoadipic acid; atherosclerosis; diabetes; lysine metabolism; obesity.
Copyright © 2025 Shi, Yang, Fu and Yang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


References
-
- Aggarwal H., Pathak P., Kumar Y., Jagavelu K., Dikshit M. (2021). Modulation of insulin resistance, dyslipidemia and serum Metabolome in iNOS knockout mice following treatment with nitrite, metformin, pioglitazone, and a combination of ampicillin and neomycin. Int. J. Mol. Sci. 23 (1), 195. 10.3390/ijms23010195 - DOI - PMC - PubMed